Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells^*.

Published in:

Veterinary & Comparative Oncology, 2012, v. 10, n. 2, p. 143, doi. 10.1111/j.1476-5829.2011.00291.x

By:

• Lawrence, J.;
• Saba, C.;
• Gogal, R.;
• Lamberth, O.;
• Vandenplas, M. L.;
• Hurley, D. J.;
• Dubreuil, P.;
• Hermine, O.;
• Dobbin, K.;
• Turek, M.

Publication type:

Article